Evidence map›Paper›PMID 29216343›Full record

ReviewILAR journal2017

Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future.

Lisa A Miller, Christopher M Royer, Kent E Pinkerton, Edward S Schelegle

Open access · bronzeAbstract readReview
In one paragraph

Review in ILAR journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Animals in Respiratory Research.International journal of molecular sciences · 2024
    Review
  12. Nonhuman primate models of pediatric viral diseases.Frontiers in cellular and infection microbiology · 2024
    Review
  13. Review
  14. Article
  15. Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD).Journal of toxicology and environmental health. Part B, Critical reviews · 2023
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lisa A MillerDepartment of Anatomy, Physiology & Cell Biology, UC Davis School of Veterinary Medicine, University of California, Davis, California.
Christopher M RoyerCalifornia National Primate Research Center, University of California, Davis, California.
Kent E PinkertonDepartment of Anatomy, Physiology & Cell Biology, UC Davis School of Veterinary Medicine and Department of Pediatrics, UC Davis School of Medicine, University of California, Davis, California.
Edward S SchelegleDepartment of Anatomy, Physiology & Cell Biology, UC Davis School of Veterinary Medicine, University of California, Davis, California.
University of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Age-Dependent Effects of E-cigarette Vaping on Host Pathogen DefenseK01OD024782 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ROYER, CHRISTOPHER MICHAEL · 2017 to 2021
$737k
NIH HHS K01 OD024782NIH HHS P51 OD011107
6 · The paper itself

Abstract

The respiratory system consists of an integrated network of organs and structures that primarily function for gas exchange. In mammals, oxygen and carbon dioxide are transmitted through a complex respiratory tract, consisting of the nasal passages, pharynx, larynx, and lung. Exposure to ambient air throughout the lifespan imposes vulnerability of the respiratory system to environmental challenges that can contribute toward development of disease. The importance of the respiratory system to human health is supported by statistics from the Centers for Disease Control and Prevention; in 2015, chronic lower respiratory diseases were the third leading cause of death in the United States. In light of the significant mortality associated with respiratory conditions that afflict all ages of the human population, this review will focus on basic and preclinical research conducted in nonhuman primate models of respiratory disease. In comparison with other laboratory animals, the nonhuman primate lung most closely resembles the human lung in structure, physiology, and mucosal immune mechanisms. Studies defining the influence of inhaled microbes, pollutants, or allergens on the nonhuman primate lung have provided insight on disease pathogenesis, with the potential for elucidation of molecular targets leading to new treatment modalities. Vaccine trials in nonhuman primates have been crucial for confirmation of safety and protective efficacy against infectious diseases of the lung in a laboratory animal model that recapitulates pathology observed in humans. In looking to the future, nonhuman primate models of respiratory diseases will continue to be instrumental for translating biomedical research for improvement of human health.

Indexed as

Disease Models, AnimalAnimalsAsthmaCommunicable DiseasesHumansPrimatesPulmonary Disease, Chronic ObstructiveRespiratory Tract DiseasesasthmaCOPDinfectious diseaseinhalationlungnonhuman primatetoxicology

Identifiers

PMID29216343
PMCPMC5886323
OpenAlexW2771957153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.